219 results
Page 3 of 11
424B5
kju nuf81
23 Dec 22
Prospectus supplement for primary offering
7:32am
8-K
8e9oq2
23 Dec 22
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
7:00am
8-K
EX-10.1
yieoibpeykqcbofuh
23 Dec 22
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
7:00am
8-K
EX-99.1
1kn8jfq2tyqp9ew
23 Dec 22
Madrigal Pharmaceuticals Announces $300+ Million in Financing Events to Advance Resmetirom Program
7:00am
8-K
e43y gq66pwmu0f
19 Dec 22
Regulation FD Disclosure
8:42am
8-K
EX-99.1
s7wjv7oa4j0pnj cjz5
3 Nov 22
Presentations and Reports 2022 Third Quarter Financial Results
8:01am
8-K
EX-99.1
21dfp
4 Aug 22
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 Second Quarter Financial Results
6:33am
8-K
EX-99.1
7itfdl
9 May 22
Madrigal Pharmaceuticals Provides Clinical and Business Updates and Reports 2022 First Quarter Financial Results
6:33am
8-K
EX-99.1
fy30 mullp0g4
24 Feb 22
Madrigal Pharmaceuticals Provides Business and Clinical Updates and Reports 2021 Fourth Quarter and Full Year Financial Results
8:01am
8-K
EX-99.1
bcwg w18ilelvh
4 Nov 21
Madrigal Pharmaceuticals Provides Corporate Update and Reports 2021 Third Quarter Financial Results
8:30am